BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity

This publication has 18 references indexed in Scilit:

• Structure of Bcl-x _L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
  Science, 1997
• X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
  Nature, 1996
• A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of Apoptosis
  Published by Elsevier ,1996
• Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2
  Journal of Biological Chemistry, 1996
• New members of the Bcl-2 family and their protein partners
  Current Opinion in Genetics & Development, 1996
• Bax-independent inhibition of apoptosis by Bcl-XL
  Nature, 1996
• CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
  Immunity, 1995
• Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
  Cell, 1995
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Interaction Cloning: Identification of a Helix-Loop-Helix Zipper Protein that Interacts with c-Fos
  Science, 1992